Skip to main content

Fiscal Wizard · Single-issue tearsheet

COAG / Jun 21, 2026 Run #7506

COAG

Hemab Therapeutics Holdings, Inc.

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark. Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand disease. It also advances multiple preclinical and discovery-stage assets. The company was founded in 2020 and is based in Cambridge, Massachusetts.

Composite verdict

F 20.1 / 100
Bearish setup · Oscillator 9 drivers · 2 gates blocking
  • Williams %R
  • Commodity Channel Index
  • Vortex Signal
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 269th of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 0%Evidence: High · 8 signals100% Bear
Momentum Bearish 21Mean-reversion Bearish 31

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Mixed

40.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Greenblatt EY 75
Free Cash Flow Yield 0
Greenblatt ROC 71
Asset Turnover 25
Return on Assets 66

Technicals Bearish

0.1 / 100

Bearish setup leads (Williams %R, Commodity Channel Index, Vortex Signal); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Williams %R 12
Vortex Signal 15
Commodity Channel Index 16

Risk Gates

2 blocking 4 caution

2 guards active, 11 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for COAG.